Debt-to-equity of HOOKIPA Pharma Inc. from 30 Sep 2019 to 31 Mar 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
HOOKIPA Pharma Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2019 to 31 Mar 2025.
  • HOOKIPA Pharma Inc. Debt-to-equity for the quarter ending 31 Mar 2025 was 56%, a 14% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

HOOKIPA Pharma Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q1 2025 56% -9.2% -14% 31 Mar 2025
Q4 2024 48% -31% -39% 31 Dec 2024
Q3 2024 54% -21% -28% 30 Sep 2024
Q2 2024 59% -5.5% -8.5% 30 Jun 2024
Q1 2024 65% +12% +24% 31 Mar 2024
Q4 2023 78% +39% +100% 31 Dec 2023
Q3 2023 75% +41% +123% 30 Sep 2023
Q2 2023 64% +31% +93% 30 Jun 2023
Q1 2023 52% +19% +56% 31 Mar 2023
Q4 2022 39% +8.8% +29% 31 Dec 2022
Q3 2022 34% +8.1% +31% 30 Sep 2022
Q2 2022 33% +7.8% +30% 30 Jun 2022
Q1 2022 34% +9.2% +38% 31 Mar 2022
Q4 2021 30% +4.9% +19% 31 Dec 2021
Q3 2021 26% -0.68% -2.6% 30 Sep 2021
Q2 2021 25% +1.7% +7.1% 30 Jun 2021
Q1 2021 24% +1.6% +7.2% 31 Mar 2021
Q4 2020 25% -11% -31% 31 Dec 2020
Q3 2020 26% -59% -69% 30 Sep 2020
Q2 2020 24% 30 Jun 2020
Q1 2020 23% 31 Mar 2020
Q4 2019 37% 31 Dec 2019
Q3 2019 85% 30 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.